Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS
Lin Elizabeth Yeu sold 13,953 Tarsus Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 4, 2026 · Filed Sep 9, 2026
On Sep 4, 2026, Lin Elizabeth Yeu (Chief Medical Officer) sold 13,953 Tarsus Pharmaceuticals, Inc. shares at an average US$87.50 for US$1.22M under a trading plan, leaving 1,590 shares. Filed Sep 9, 2026 (Form 4).
- Sold
- 13,953 shares
- Price
- US$87.50 average (US$85.00 to US$90.00)
- Value
- US$1.22M
- Holding after
- 1,590 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | Sale | 5,387 | US$85.00 | 7,933 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 5,386 | US$90.00 | 2,547 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 1,590 | US$85.00 | 3,180 | Indirect |
| Sep 4, 2026 | Common Stock | Sale | 1,590 | US$90.00 | 1,590 | Indirect |
Source
Related
- Tarsus Pharmaceuticals, Inc.
- Lin Elizabeth Yeu
- Tarsus Pharmaceuticals, Inc. shareholders
- Form 4 · Lin Elizabeth Yeu · Sep 3, 2026
- Form 4 · Pyott David E I · Sep 17, 2026
- Form 4 · Yarno Wendy L · Sep 17, 2026
- Form 4 · Link William J Phd · Sep 17, 2026
- Form 4 · Azamian Bobak R. · Sep 9, 2026
- Form 4 · Neervannan Seshadri · Sep 9, 2026